Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia
Latest Information Update: 06 Sep 2024
At a glance
- Drugs Goserelin (Primary)
- Indications Muscular atrophy; Prostate cancer
- Focus Adverse reactions
- 04 Sep 2024 Status changed from active, no longer recruiting to completed.
- 30 Aug 2024 Planned End Date changed from 31 Aug 2024 to 31 Aug 2025.
- 30 Aug 2024 Planned primary completion date changed from 31 Aug 2023 to 1 Sep 2024.